EMO
name pending profile ingest
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 29 | -1 | 2.73M | $136.82M | +3 | −4 |
| Q1 2026 | 31 | +4 | 2.74M | $144.94M | +5 | −1 |
| Q4 2025 | 27 | 0 | 2.73M | $121.92M | — | — |
| Q3 2025 | 3 | -1 | 1.26M | $56.50M | — | −1 |
| Q2 2025 | 1 | — | 16 | $756 | — | — |
| Q4 2024 | 1 | 0 | 15.72K | $731,516 | — | — |
| Q3 2024 | 1 | +1 | 29.55K | $1.25M | +1 | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Morgan Stanley ✦ | 1.23M | — | $55.21M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Morgan Stanley ✦ | 1.23M | — | $55.21M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Morgan Stanley ✦ | 1.23M | — | $55.21M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Morgan Stanley ✦ | 1.23M | — | $55.21M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Morgan Stanley ✦ | 1.23M | — | $55.21M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | JPMorgan Chase ✦ | 24.05K | — | $1.08M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | JPMorgan Chase ✦ | 24.05K | — | $1.08M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | JPMorgan Chase ✦ | 24.05K | — | $1.08M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | JPMorgan Chase ✦ | 24.05K | — | $1.08M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Goldman Sachs Group ✦ | 4.64K | — | $208,339 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| BlackRock | $756 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 116 holders, 5.55M shares, $253.91M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.